HLOSF 주가 차트
HLOSF 수입
Healios K.K.
$1.8
0%
$0
종가: Jun 18, 16:00:00 GMT-4
$1.8
0%
$0
프리마켓: Jun 22, 04:37:57 GMT-4
뒤로
Healios K.K. (HLOSF) 수입
주요 통계
이전 종가
$1.8
시가
$2.7
일일 범위
$1.8 - $2.7
52주 범위
$1.8 - $4.45
거래량
100
평균 거래량
33
배당수익률
--
EPS(TTM)
-0.17
시가총액
$243.0M
HEALIOS K K란 무엇인가요?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 75 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
